47 ALKYLATING AGENT THERAPY PROMOTES THE EXPANSION OF PROGENITORS HAPLOINSUFFICIENT FOR DEL(5Q) GENES, EGR1 AND APC, TOGETHER WITH KNOCKDOWN OF TRP53 LEADING TO MYELOID NEOPLASMS